ChertcoffANgHSZhuF, et al. Polypharmacy and multiple sclerosis: A population-based study. Mult Scler J. Epub ahead of print 27 October 2022. DOI: 10.1177/13524585221122207.
2.
World Health Organization. Medication safety in polypharmacy. Geneva: World Health Organization, 2019.
3.
BourdetteDHerinkM.Polypharmacy in multiple sclerosis: More is not necessarily better. Mult Scler. Epub ahead of print 14 October 2022. DOI: 10.1177/13524585221129964.
4.
ThelenJZvonarevVLamS, et al. Polypharmacy in multiple sclerosis: Current knowledge and future directions. Mo Med2021; 118(3): 239–245.
5.
FrahmNHeckerMZettlUK.Polypharmacy among patients with multiple sclerosis: A qualitative systematic review. Expert Opin Drug Saf2020; 19(2): 139–145.
